Treatment stratification in B-cell PTLD after solid organ transplantation (SOT) by international prognostic index (IPI) and response to rituximab: Interim results from the PTLD-2 trial.

Ralf Trappe,Christian Koenecke,Martin Dreyling,Christiane Pott,Ulrich Duehrsen,Norbert Meidenbauer,Dennis Hahn,Michael Heuser,Christian Schmidt,Matthias Ritgen,Reiner Siebert,Ilske Oschlies,Ioannis Anagnostopoulos,Heiner Zimmermann,Dptldsg

Treatment stratification in B-cell PTLD after solid organ transplantation (SOT) by international prognostic index (IPI) and response to rituximab: Interim results from the PTLD-2 trial.

2020

Ralf Trappe
Christian Koenecke
Martin Dreyling
Christiane Pott
Ulrich Duehrsen
Norbert Meidenbauer
Dennis Hahn
Michael Heuser
Christian Schmidt
Matthias Ritgen
Reiner Siebert
Ilske Oschlies
Ioannis Anagnostopoulos
Heiner Zimmermann
Dptldsg

8045Background: The PTLD-1 trials have established risk-stratified sequential treatment of B-cell PTLD. After rituximab induction, patients (pts) in complete remission (25 %) received rituximab con...

Keywords:

Oncology
Internal medicine
B cell
solid organ transplantation
Interim
Pathology
Rituximab
International Prognostic Index
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations